Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ceftobiprole: Preliminary Phase III data

Preliminary data from a double-blind Phase III trial in 781 patients showed that ceftobiprole met the primary endpoint

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE